Neovacs Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Neovacs has a total shareholder equity of €48.8M and total debt of €650.6K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are €52.6M and €3.7M respectively.
Belangrijke informatie
1.3%
Verhouding schuld/eigen vermogen
€650.59k
Schuld
| Rente dekkingsratio | n/a |
| Contant | €887.09k |
| Aandelen | €48.84m |
| Totaal verplichtingen | €3.72m |
| Totaal activa | €52.56m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: ALNEV's short term assets (€3.8M) exceed its short term liabilities (€3.7M).
Langlopende schulden: ALNEV's short term assets (€3.8M) exceed its long term liabilities (€7.6K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ALNEV has more cash than its total debt.
Schuld verminderen: ALNEV's debt to equity ratio has reduced from 2.7% to 1.3% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if ALNEV has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if ALNEV has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.